US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
ENDRA Life Sciences Inc (NDRA)
ENDRA Life Sciences Inc (NDRA) ニュース

NDRA

ENDRA Life Sciences (NDRA)

ENDRA Life Sciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NDRA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/11	06 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/11	06 : 17	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/07	21 : 00	Business Wire	ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/02	21 : 00	Business Wire	ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/03/29	05 : 05	Business Wire	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/03/21	21 : 00	Business Wire	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/02/27	22 : 00	Business Wire	ENDRA Life Sciences Installs First TAEUS System in the UK	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/02/24	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/02/21	22 : 00	Business Wire	New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/02/14	22 : 30	Business Wire	ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/12/30	07 : 07	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/29	22 : 00	Business Wire	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/27	22 : 00	Business Wire	ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/15	06 : 05	Business Wire	ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/15	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/08	22 : 00	Business Wire	ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/08	06 : 05	Business Wire	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/06	22 : 00	Business Wire	ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/09/07	21 : 00	Business Wire	Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/30	21 : 00	Business Wire	ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/23	21 : 00	Business Wire	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	05 : 53	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	05 : 45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	05 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	05 : 05	Business Wire	ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	02 : 30	Business Wire	ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/10	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/01	21 : 00	Business Wire	ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/07/26	05 : 03	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/07/26	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc

Showing the most relevant articles for your search:NASDAQ:NDRA

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Euro

Bank of America

Financial Select Sector

American Express

Invesco QQQ Trust Series 1

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約